Form 4 for BSX Boston Scientific
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0001225208-24-009878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | 2024-11-08 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $24.55 | +17.4K | 70.3K | +33% | +$426.2K |
| D | 2024-11-12 | 2024-11-08 | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale+OE | $87.66 | -30.6K | 39.7K | -44% | -$2.68M |
| D | 2024-11-12 | 2024-11-08 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | -17.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | M | A | 17,362 | $24.55 | 70,286 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-08 | S | D | 30,580 | $87.66 | 39,706 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $87.324 to $87.94, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-11-08 | M | D | 17,362 | $0.00 | 0 | D | $24.55 · — to 2027-02-28 | 17,362 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |